Cargando…

Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2

Coronavirus causes a disease with high infectivity and pathogenicity, especially SARS in 2003, MERS in 2012, and COVID-2019 currently. The spike proteins of these coronaviruses are critical for host cell entry by receptors. Thus, searching for broad-spectrum anti-coronavirus candidates, such as spik...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shaopeng, Zhu, Yuying, Xu, Jiaruo, Yao, Guangtao, Zhang, Pei, Wang, Mengge, Zhao, Yongfang, Lin, Guoqiang, Chen, Hongzhuan, Chen, Lili, Zhang, Jiange
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier GmbH. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531286/ https://www.ncbi.nlm.nih.gov/pubmed/33041173 http://dx.doi.org/10.1016/j.phymed.2020.153364

Ejemplares similares

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
por: Xiang, Yusen, et al.
Publicado: (2021)

Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment
por: Li, Jingjing, et al.
Publicado: (2021)

Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
por: Xiang, Yusen, et al.
Publicado: (2023)

Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses
por: Wang, Ruyu, et al.
Publicado: (2023)

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)
por: Wang, Ruyu, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

The Interaction of the Transmembrane Domain of SARS-CoV-2 E-Protein with Glycyrrhizic Acid in Lipid Bilayer
por: Kononova, Polina A., et al.
Publicado: (2023)

Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein
por: Chen, Yao, et al.
Publicado: (2023)

Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2
por: Zheng, Wenjiang, et al.
Publicado: (2021)

Novel Inhibitory Effects of Glycyrrhizic Acid on the Accumulation of Advanced Glycation End Product and Its Receptor Expression
por: Cheng, Hong Sheng, et al.
Publicado: (2014)

Advances in the roles of glycyrrhizic acid in cancer therapy
por: Zhang, Yuqian, et al.
Publicado: (2023)

Glycyrrhizic acid exerts protective effects against hypoxia/reoxygenation-induced human coronary artery endothelial cell damage by regulating mitochondria
por: Tang, Quan, et al.
Publicado: (2020)

Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
por: Gao, Lili, et al.
Publicado: (2015)

B cell-related tertiary lymphoid structure may exert inhibitory effects on lung adenocarcinoma and SARS-COV-2
por: Sun, Kang, et al.
Publicado: (2023)

Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats
por: GAO, YUQIN, et al.
Publicado: (2015)

Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure–activity relationships
por: Lin, Jung-Chung, et al.
Publicado: (2008)

LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
por: Song, Jaewon, et al.
Publicado: (2021)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors
por: Fatima, Syeda Warisul, et al.
Publicado: (2022)

Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model
por: Jeong, Ju Hwan, et al.
Publicado: (2023)

Extraction of Glycyrrhizic Acid and Glabridin from Licorice
por: Tian, Minglei, et al.
Publicado: (2008)

Glycyrrhizic acid derivatives as Dengue virus inhibitors
por: Baltina, Lidia A., et al.
Publicado: (2019)

Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid
por: Wang, Wei, et al.
Publicado: (2013)

Clinical efficacy and security of glycyrrhizic acid preparation in the treatment of anti-SARS-CoV-2 drug-induced liver injury: a protocol of systematic review and meta-analysis
por: Tian, Xia, et al.
Publicado: (2021)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells
por: Peng, Shoujiao, et al.
Publicado: (2023)

Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid
por: Ni, Qingqiang, et al.
Publicado: (2022)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity
por: Cano-Muñoz, Mario, et al.
Publicado: (2022)

The Effects of Sweet Foods on the Pharmacokinetics of Glycyrrhizic Acid by icELISA
por: Jiang, Bingqian, et al.
Publicado: (2017)

Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid
por: Vardhan, Seshu, et al.
Publicado: (2022)

Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells
por: Wang, Mengge, et al.
Publicado: (2022)

Thermally controlled biotransformation of glycyrrhizic acid via an asymmetric temperature-responsive polyurethane membrane
por: Wu, Xiuhong, et al.
Publicado: (2018)

Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats
por: Yuan, Tianjie, et al.
Publicado: (2020)

Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
por: Li, Jian-yuan, et al.
Publicado: (2014)

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2021)

Mechanical activation of spike fosters SARS-CoV-2 viral infection
por: Hu, Wei, et al.
Publicado: (2021)

SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells
por: Zheng, Luping, et al.
Publicado: (2021)

Glycyrrhizic acid ameliorates myocardial ischemic injury by the regulation of inflammation and oxidative state
por: Xu, Chongli, et al.
Publicado: (2018)

Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction
por: Ho, Tin-Yun, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_feh8erqos2jinqkc5gk8k3634f